LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 1,864 pages found matching %3Cscript%3Ealert%28%27What_Security?%27%29%3C/script%3E- Panacryl Sutures: Another headache for Ethicon
Feb-24-07 Des Moines, IA The recall of Panacryl Sutures last year, four years after the manufacturer took them off store shelves, is only the latest in a string of headaches for Ethicon, makers of Panacryl. Much like what happened with Ethicon's Vicryl brand of sutures, the company will likely face a string of lawsuits because of problems with the Panacryl Sutures... - More Zyprexa Postcards From the Edge
Feb-18-07 Washington, DC: On February 13, 2007, Judge Jack Weinstein issued a permanent injunction, prohibiting attorney, Jim Gottstein, and Dr David Egilman, an expert witness in litigation involving Zyprexa , from further disseminating certain Eli Lilly documents that were sealed with a court order until Mr Gottstein released them to the media in December 2006... - UnumProvident Tells Customer to Work Despite Internal Bleeding
Feb-17-07 Bethpage, NY: Thomas Villani paid his UnumProvident premiums for years while he worked at Verizon. According to the terms of his policy, in case of illness lasting for more than a year he would receive 65 percent of his income and Verizon would hold his job for another year. Unfortunately, UnumProvident refused to hold up their end of the contract. In... - Trail of Paxil Suicides Leads To GlaxoSmithKline
Feb-14-07 Washington, DC: On January 29, 2007, BBC-One broadcast, "Secrets of the Drug Trials," a Panorama program based on an investigation by reporter, Shelley Jofre, which revealed how GlaxoSmithKline misled doctors into prescribing Paxil off-label to children, even after its own clinical trials found that kids could become suicidal when taking the drug. The... - Kugel Mesh Patch: Keeping Track of the Recalls
Feb-14-07 Belgium, WI: With so many recalls in the past 14 months, keeping track of Kugel Mesh Patches can be difficult. People who were relieved that their patches were not initially recalled are now learning that the recalls have been expanded to include new lots and product codes. Other people who had their patch fail are left wondering if their replacement... - Patients with Drug-Eluting Stents Warned to Stay on Meds
Feb-13-07 Los Angeles, CA: A number of organizations have issued a joint advisory recommending that any one who has a drug-eluting stent implanted should take blood thinners such as Plavix for a year after surgery. The advisory was issued by the American Heart Association, the American College of Cardiology, the Society for Cardiovascular Angiography and Int... - Consequences of Rampant Off-Label Prescribing of Depakote
Feb-7-07 Washington, DC: The antiepileptic drug, Depakote , is one of the most heavily prescribed medications for off-label use. The Epilepsy Foundation reports that there are an estimated 1 million women in the US with epilepsy, but the number of women being treated with antiepileptics is two to three times higher than the number of women with the disorder. Ex... - Kugel Mesh Recall Updated to Class 1
Feb-7-07 New York, NY: Earlier this month, the United States Food and Drug Administration (FDA) announced that it had upgraded the recall category of several Composix Kugel Mesh Hernia Patches to Class 1. The announcement, issued February 1, was made because exposure to defective Kugel Mesh Patches carried a reasonable probability of causing serious health pro... - Eli Lilly's Zyprexa Woes not Finished Yet
Feb-2-07 Washington, DC: Eli Lilly, makers of Zyprexa , may finally be feeling some of the sting of recent lawsuits. Late last month Eli Lilly announced that its fourth-quarter earnings had dropped, likely due to recent settlements of lawsuits related to Zyprexa. According to a report in the New York Times, Eli Lilly made $132 million in its fourth quarter; d... - Zyprexa Injury Clock Keeps Ticking Away
Feb-2-07 San Jose, CA The on-going legal battle over the disclosure of secret Eli Lilly documents that reveal the serious health risks associated with Zyprexa and the company's off-label promotion of the drug involves a matter of grave public concern. But observers on the sidelines of this courtroom circus say the conduct of the judge in helping Lilly keep d... - Unborn Baby has Birth Defects from SSRI
Feb-2-07 Toronto, ON Diane Johnson started taking Celexa , an SSRI, in January, 2005. She is now 27 weeks pregnant and an ultrasound shows that her baby has a clubfoot. Nobody told her about the risks associated with SSRIs - in fact she told her doctor about them! "When I was prescribed Celexa I had two children and I wasn't coping very well," said Diane Johns... - GlaxoSmithKline Defamed With Truth About Paxil
Jan-31-07 London, UK: GlaxoSmithKline has labeled the allegations made in a Panorama television program that said the company had suppressed the results of clinical trials that showed Paxil was ineffective and caused children to become suicidal "defamatory." According to the January 30, 2007, Guardian, an official at the company said Glaxo had looked into takin... - No End in Sight for Fen-Phen Lawsuits
Jan-29-07 Rutherford, NJ: On December 5, 2006, five women with ages ranging from 53 to 71, who took the appetite suppressants drugs known as fen-phen in 1996 and 1997, filed lawsuits against Wyeth Pharmaceuticals after being diagnosed with a life-threatening lung disorder. These lawsuits demonstrate that the harm caused by fen-phen can surface many years after a... - Credit Card Rate Hikes: No one Wins
Jan-29-07 Tucson, AZ: One of the worst types of credit card rate hike is a practice known as universal default. Unfortunately, it's a practice that very few people know about until they're the victims of it. Under universal default a credit card issuer can increase the interest on your card if you are late making a payment on any of a number of bills including... - Ethicon's Panacryl Lawsuits
Jan-28-07 New York, NY: Just like history repeating itself, Ethicon now faces liability lawsuits similar to its Vicryl sutures lawsuits more than a decade ago. This time the product is Panacryl sutures. Ethicon was sued after a recall of 3.5 million packages of its Vicryl brand of sutures in 1994 -- the sutures were contaminated due to a faulty sterilizer. Now,... - Kugel Mesh Recalls - A Timeline
Jan-25-07 Cranston, RI: Over the past 13 months, Davol, Inc., makers of Kugel Mesh Hernia Patches , issued a recall and then expanded it twice. Here is a timeline of the Kugel Mesh Patch recalls. December 27, 2005: C.R. Bard notifies US customers of a voluntary Class I recall of the Bard Composix Kugel Mesh X-Large Patch by letter delivered via Federal Express... - Off-Label Prescribing of Pain Lollipops Turns Deadly
Jan-24-07 Salt Lake City, UT: The painkilling lollipop, Actiq , is approved to treat chronic pain in cancer patients who are already on an opioid drug. But a recent study by Prime Therapeutics found the drug is being prescribed off-label for unapproved uses nearly 90% of the time. For those suffering with the agonizing pain of late stage cancer, the painkiller o... - Experts Predict Many Cases of Permax Heart Valve Damage
Jan-21-07 Washington, DC Nearly three years ago, HealthDay News reported that a study had confirmed previous findings that the drug, Permax , used to treat Parkinson's disease, could damage heart valves and surgery would be needed to correct the problem. The April 28, 2004, report quoted the lead researcher, Dr Richard Dewey Jr, an associate professor from the U... - PPH and Fen-Phen: Some Lawsuits Settled
Jan-20-07 Savannah, GA Primary Pulmonary Hypertension (PPH) is a serious lung disorder that can lead to heart failure and potentially death. There is no specific known cause of PPH; all that is known is that it causes increased pressure in the pulmonary artery and a decrease in the amount of blood entering the lungs. Although some lawsuits regarding fen-phen an... - More Trasylol Victims
Jan-18-07 St. Louis, MO Trasylol is an injectable drug made by Bayer. It is used to prevent excessive blood loss during heart surgery, mainly for patients undergoing coronary artery bypass grafting (CABG). Trasylol has been in the news lately - it has now been linked to increased risk of death, kidney or renal failure, heart attacks, strokes and encephalopathy...